{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:53:56Z","timestamp":1768823636535,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["100195374"],"award-info":[{"award-number":["100195374"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008678","name":"Universit\u00e4t Leipzig","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008678","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.chroma.2021.462095","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T11:10:22Z","timestamp":1616670622000},"page":"462095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Bio-activation of simeprevir in liver microsomes and characterization of its glutathione conjugates by liquid chromatography coupled to ultrahigh-resolution quadrupole time-of-flight mass spectrometry"],"prefix":"10.1016","volume":"1645","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0575-2458","authenticated-orcid":false,"given":"Mohamed M.Y.","family":"Kaddah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Billig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Oehme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Birkemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2021.462095_bib0001","series-title":"PubChem Compound Summary for CID 24873435","year":"2020"},{"key":"10.1016\/j.chroma.2021.462095_bib0002","unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012, Simeprevir. [Updated 18 January 2018]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548277\/. (Accessed 9 January 2019)."},{"issue":"3","key":"10.1016\/j.chroma.2021.462095_bib0003","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1389200054021799","article-title":"A comprehensive listing of bioactivation pathways of organic functional groups","volume":"6","author":"Kalgutkar","year":"2005","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.chroma.2021.462095_bib0004","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jchromb.2014.02.028","article-title":"Determination of simeprevir: a novel, hepatitis C protease inhibitor in human plasma by high-performance liquid chromatography-tandem mass spectrometry","volume":"958","author":"Vanwelkenhuysen","year":"2014","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.chroma.2021.462095_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2019.04.048","article-title":"A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological study","volume":"1120","author":"Ferrari","year":"2019","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.chroma.2021.462095_bib0006","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jchromb.2019.01.024","article-title":"Quantification of second generation direct-acting antivirals daclatasvir, elbasvir, grazoprevir, ledipasvir, simeprevir, sofosbuvir and velpatasvir in human plasma by UPLC-MS\/MS","volume":"1110-1111","author":"van Seyen","year":"2019","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.chroma.2021.462095_bib0007","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jpba.2016.04.031","article-title":"A UHPLC-MS\/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir\/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma","volume":"125","author":"Ariaudo","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.chroma.2021.462095_bib0008","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1021\/tx0002583","article-title":"Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity","volume":"14","author":"Guengerich","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.chroma.2021.462095_bib0009","doi-asserted-by":"crossref","unstructured":"\u0141. Rajski, M.M. G\u00f3mez-Ramos, A.R. Fern\u00e1ndez-Alba, Chapter 5 - Application of LC-time-of-flight and Orbitrap-MS\/MS for pesticide residues in fruits and vegetables, in: S. P\u00e9rez, P. Eichhorn, D. Barcel\u00f3 (Eds.), Comprehensive Analytical Chemistry, Elsevier2016, pp. 119-154. 10.1016\/bs.coac.2016.02.001.","DOI":"10.1016\/bs.coac.2016.02.001"},{"key":"10.1016\/j.chroma.2021.462095_bib0010","doi-asserted-by":"crossref","unstructured":"M.K. Ladumor, S. Tiwari, A. Patil, K. Bhavsar, S. Jhajra, B. Prasad, S. Singh, Chapter 7 - High-resolution mass spectrometry in metabolite identification, in: S. P\u00e9rez, P. Eichhorn, D. Barcel\u00f3 (Eds.), Comprehensive Analytical Chemistry, Elsevier2016, pp. 199-229. 10.1016\/bs.coac.2016.01.004.","DOI":"10.1016\/bs.coac.2016.01.004"},{"issue":"19","key":"10.1016\/j.chroma.2021.462095_bib0011","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1021\/ac1014645","article-title":"Identification of a new antidepressant and its glucuronide metabolite in water samples using liquid chromatography\/quadrupole time-of-flight mass spectrometry","volume":"82","author":"Ferrer","year":"2010","journal-title":"Analytical Chemistry"},{"issue":"20","key":"10.1016\/j.chroma.2021.462095_bib0012","doi-asserted-by":"crossref","first-page":"9581","DOI":"10.1021\/ac4016984","article-title":"Analytical methodologies for the detection of sucralose in water","volume":"85","author":"Ferrer","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2021.462095_bib0013","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.pa.30.040190.001125","article-title":"Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals","volume":"30","author":"Nelson","year":"1990","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.chroma.2021.462095_bib0014","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0016-5085(00)70192-2","article-title":"Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver","volume":"118","author":"Maddrey","year":"2000","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.chroma.2021.462095_bib0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00002018-200124070-00001","article-title":"Drug-induced liver disorders: implications for drug development and regulation","volume":"24","author":"Kaplowitz","year":"2001","journal-title":"Drug Saf."},{"issue":"4","key":"10.1016\/j.chroma.2021.462095_bib0016","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-200730040-00001","article-title":"Drug-induced liver injury","volume":"30","author":"Abboud","year":"2007","journal-title":"Drug Safety"},{"issue":"1","key":"10.1016\/j.chroma.2021.462095_bib0017","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/03602532.2011.605791","article-title":"Metabolic activation in drug-induced liver injury","volume":"44","author":"Leung","year":"2012","journal-title":"Drug Metab. Rev."},{"issue":"11","key":"10.1016\/j.chroma.2021.462095_bib0018","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1021\/jm300065h","article-title":"Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure\u2013activity relationships and discovery strategies to mitigate drug\u2013drug interaction risks","volume":"55","author":"Orr","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.chroma.2021.462095_bib0019","doi-asserted-by":"crossref","unstructured":"J. Lee, R.S. Obach, M.B. Fisher, Drug metabolizing enzymes: Cytochrome P450 and other enzymes in drug discovery and development, CRC Press2003. 10.1201\/9781420028485.","DOI":"10.1201\/9781420028485"},{"issue":"2","key":"10.1016\/j.chroma.2021.462095_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/1389200003339081","article-title":"Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions","volume":"1","author":"Uetrecht","year":"2000","journal-title":"Current Drug Metabolism"},{"issue":"18","key":"10.1016\/j.chroma.2021.462095_bib0021","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S1359-6446(03)02816-2","article-title":"Screening for the potential of a drug candidate to cause idiosyncratic drug reactions","volume":"8","author":"Uetrecht","year":"2003","journal-title":"Drug Discov. Today"},{"issue":"6","key":"10.1016\/j.chroma.2021.462095_bib0022","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/chemse\/bjw056","article-title":"Sampling the body odor of primates: cotton swabs sample semivolatiles rather than volatiles","volume":"41","author":"Birkemeyer","year":"2016","journal-title":"Chemical Senses"},{"key":"10.1016\/j.chroma.2021.462095_bib0023","unstructured":"Innovation with integrity - UHR-TOF MS. http:\/\/bruker.poznan.pl\/wp-content\/uploads\/2018\/12\/brochure-impact-II.pdf. (Accessed 12 April 2020)."},{"issue":"6","key":"10.1016\/j.chroma.2021.462095_bib0024","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1021\/tx4001144","article-title":"Bioactivation of sitaxentan in liver microsomes, hepatocytes, and expressed human P450s with characterization of the glutathione conjugate by liquid chromatography tandem mass spectrometry","volume":"26","author":"Erve","year":"2013","journal-title":"Chem. Res. Toxicol."},{"issue":"21","key":"10.1016\/j.chroma.2021.462095_bib0025","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.1021\/ac071119u","article-title":"Detection and structural characterization of glutathione-trapped reactive metabolites using liquid chromatography\u2212high-resolution mass spectrometry and mass defect filtering","volume":"79","author":"Zhu","year":"2007","journal-title":"Analytical Chemistry"},{"issue":"1","key":"10.1016\/j.chroma.2021.462095_bib0026","volume":"74","author":"Knights","year":"2016","journal-title":"In vitro drug metabolism using liver microsomes"},{"key":"10.1016\/j.chroma.2021.462095_bib0027","series-title":"Guideline on bioanalytical method validation","author":"European Medicines","year":"2012"},{"issue":"13","key":"10.1016\/j.chroma.2021.462095_bib0028","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2021.462095_bib0029","series-title":"Competitive Fragmentation Modeling for Metabolite Identification","year":"2020"},{"issue":"5","key":"10.1016\/j.chroma.2021.462095_bib0030","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00216-017-0814-8","article-title":"Rapid screening and characterization of glutathione-trapped reactive metabolites using a polarity switch-based approach on a high-resolution quadrupole orbitrap mass spectrometer","volume":"410","author":"Wang","year":"2018","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"5","key":"10.1016\/j.chroma.2021.462095_bib0031","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1021\/ac702232r","article-title":"High-throughput screening and characterization of reactive metabolites using polarity switching of hybrid triple quadrupole linear ion trap mass spectrometry","volume":"80","author":"Wen","year":"2008","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.chroma.2021.462095_bib0032","series-title":"The emerging role of human esterases, drug metabolism and pharmacokinetics","author":"Fukami","year":"2012"},{"key":"10.1016\/j.chroma.2021.462095_bib0033","unstructured":"Safety Data Sheet, Cyclopropansulfonamide. https:\/\/www.sigmaaldrich.com\/MSDS\/MSDS\/DisplayMSDSPage.do?country=EG&language=en&productNumber=674060&brand=ALDRICH&PageToGoToURL=https%3A%2F%2Fwww.sigmaaldrich.com%2Fcatalog%2Fproduct%2Faldrich%2F674060%3Flang%3Den. (Accessed 30 March 2020)."},{"issue":"6","key":"10.1016\/j.chroma.2021.462095_bib0034","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s40495-016-0076-8","article-title":"Challenges and opportunities with predicting in vivo phase II metabolism via glucuronidation from in vitro data","volume":"2","author":"Ge","year":"2016","journal-title":"Current Pharmacology Reports"},{"issue":"5","key":"10.1016\/j.chroma.2021.462095_bib0035","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1021\/ac702232r","article-title":"High-throughput screening and characterization of reactive metabolites using polarity switching of hybrid triple quadrupole linear ion trap mass spectrometry","volume":"80","author":"Wen","year":"2008","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.chroma.2021.462095_bib0036","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/03602532.2014.984813","article-title":"Practical approaches to resolving reactive metabolite liabilities in early discovery","volume":"47","author":"Dalvie","year":"2015","journal-title":"Drug Metab. Rev."},{"issue":"4","key":"10.1016\/j.chroma.2021.462095_bib0037","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrd3408","article-title":"Managing the challenge of chemically reactive metabolites in drug development","volume":"10","author":"Park","year":"2011","journal-title":"Nature reviews. Drug discovery"},{"issue":"7","key":"10.1016\/j.chroma.2021.462095_bib0038","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/dmd.113.051839","article-title":"Reactive metabolite trapping studies on imidazo- and 2-methylimidazo[2,1-b]thiazole-based inverse agonists of the ghrelin receptor","volume":"41","author":"Kalgutkar","year":"2013","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"issue":"1","key":"10.1016\/j.chroma.2021.462095_bib0039","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0960-894X(96)00580-X","article-title":"Synthesis and biological evaluation of 5,6-diarylimidazo[2.1-b]thiazole as selective COX-2 inhibitors","volume":"7","author":"Th\u00e9rien","year":"1997","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"1","key":"10.1016\/j.chroma.2021.462095_bib0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0960-894X(96)00581-1","article-title":"Characterization of the in vitro oxidative metabolites of the COX-2 selective inhibitor L-766,112","volume":"7","author":"Trimble","year":"1997","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"6","key":"10.1016\/j.chroma.2021.462095_bib0041","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1124\/dmd.108.020545","article-title":"Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug","volume":"36","author":"Bauman","year":"2008","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"key":"10.1016\/j.chroma.2021.462095_bib0042","unstructured":"Clinical pharmacology and biopharmaceutics review of simeprevir, 2013. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2013\/205123Orig1s000ClinPharmR.pdf. (Accessed 15 December 2020)."},{"issue":"11","key":"10.1016\/j.chroma.2021.462095_bib0043","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"issue":"9","key":"10.1016\/j.chroma.2021.462095_bib0044","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(94)90520-7","article-title":"Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance","volume":"47","author":"Houston","year":"1994","journal-title":"Biochemical pharmacology"},{"key":"10.1016\/j.chroma.2021.462095_bib0045","series-title":"Casarett and Doull's toxicology: the basic science of poisons","first-page":"161","article-title":"Chapter 6 - Biotransformation of xenobiotics","author":"Parkinson","year":"2008"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967321002193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967321002193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T06:06:26Z","timestamp":1758261986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967321002193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":45,"alternative-id":["S0021967321002193"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2021.462095","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bio-activation of simeprevir in liver microsomes and characterization of its glutathione conjugates by liquid chromatography coupled to ultrahigh-resolution quadrupole time-of-flight mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2021.462095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"462095"}}